VR Eye Movement Monitor Helps Assess Concussion
By HospiMedica International staff writers Posted on 21 Oct 2021 |
Image: The Eye-Sync device with the Samsung Gear VR headset (Photo courtesy of SyncThink)
A virtual reality (VR) eye-tracking platform provides objective measurements to aid in diagnosis of mild traumatic brain injury (TBI).
The SyncThink (Holliston, MA, USA) Eye-Sync device consists of a VR headset with infrared (IR) cameras that track eye movement, helping clinicians to objectively evaluate visual impairments, monitor recovery, and support the rehabilitation of ocular-motor and ocular-vestibular deficits. Eye-Sync includes smooth pursuit (clockwise and anti-clockwise), vestibule-ocular reflex (VOR), and saccade (horizontal and vertical) based 60-second assessments that objectively measure eye movements, and also offers multiple modalities to train dynamic vision.
Following assessment, the VR headset connects wirelessly to a tablet device, where results can be viewed within sixty seconds. Eye-Sync is available with the Pico (San Francisco, CA, USA) Neo 2 Eye or the Samsung (Seoul, Korea) Gear Bluetooth enabled VR headsets; a Samsung S5e android tablet; a protective carrying case; paradigms for patient assessment, therapy, and training; electronic medical record (EMR) integration and rest API access; and secure, HIPAA compliant data storage.
“SyncThink develops revolutionary eye-tracking technology and analytics, in a virtual reality environment. With millions of concussions occurring each year, the need for a rapid, mobile and most importantly, objective metric for impairment and recovery is clear,” said Laura Yecies, CEO of SyncThink. “SyncThink remains dedicated to developing technology to allow everyone from athletes to patients to objectively monitor and improve their brain health and performance.”
The technology is designed to measure variance in synchronization abilities, or how much error is produced when interacting with visual cues. Each assessment is designed to identify the quality of performance with respect to synchronizing eye movement with a moving object, or by examining gaze fixation. Concussion, attention deficit hyperactivity disorder (ADHD), Parkinson’s disease (PD), and other neurodegenerative disorders all have unique synchronization deficits, providing a biomarker of impairment and/or pathology.
Related Links:
SyncThink
Pico
Samsung
The SyncThink (Holliston, MA, USA) Eye-Sync device consists of a VR headset with infrared (IR) cameras that track eye movement, helping clinicians to objectively evaluate visual impairments, monitor recovery, and support the rehabilitation of ocular-motor and ocular-vestibular deficits. Eye-Sync includes smooth pursuit (clockwise and anti-clockwise), vestibule-ocular reflex (VOR), and saccade (horizontal and vertical) based 60-second assessments that objectively measure eye movements, and also offers multiple modalities to train dynamic vision.
Following assessment, the VR headset connects wirelessly to a tablet device, where results can be viewed within sixty seconds. Eye-Sync is available with the Pico (San Francisco, CA, USA) Neo 2 Eye or the Samsung (Seoul, Korea) Gear Bluetooth enabled VR headsets; a Samsung S5e android tablet; a protective carrying case; paradigms for patient assessment, therapy, and training; electronic medical record (EMR) integration and rest API access; and secure, HIPAA compliant data storage.
“SyncThink develops revolutionary eye-tracking technology and analytics, in a virtual reality environment. With millions of concussions occurring each year, the need for a rapid, mobile and most importantly, objective metric for impairment and recovery is clear,” said Laura Yecies, CEO of SyncThink. “SyncThink remains dedicated to developing technology to allow everyone from athletes to patients to objectively monitor and improve their brain health and performance.”
The technology is designed to measure variance in synchronization abilities, or how much error is produced when interacting with visual cues. Each assessment is designed to identify the quality of performance with respect to synchronizing eye movement with a moving object, or by examining gaze fixation. Concussion, attention deficit hyperactivity disorder (ADHD), Parkinson’s disease (PD), and other neurodegenerative disorders all have unique synchronization deficits, providing a biomarker of impairment and/or pathology.
Related Links:
SyncThink
Pico
Samsung
Latest Critical Care News
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events